Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Receivables (2016 - 2025)

Cosmos Health's Receivables history spans 12 years, with the latest figure at $22.8 million for Q4 2025.

  • Quarterly results put Receivables at $22.8 million for Q4 2025, up 39.26% from a year ago — trailing twelve months through Dec 2025 was $22.8 million (up 39.26% YoY), and the annual figure for FY2025 was $22.8 million, up 39.26%.
  • Receivables for Q4 2025 was $22.8 million at Cosmos Health, up from $18.0 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $30.1 million in Q3 2021 to a low of $456741.0 in Q1 2024.
  • The 5-year median for Receivables is $23.0 million (2023), against an average of $19.2 million.
  • The sharpest move saw Receivables surged 631.92% in 2023, then tumbled 98.2% in 2024.
  • Year by year, Receivables stood at $29.8 million in 2021, then fell by 7.65% to $27.5 million in 2022, then decreased by 15.34% to $23.3 million in 2023, then fell by 29.71% to $16.4 million in 2024, then soared by 39.26% to $22.8 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $22.8 million, $18.0 million, and $574985.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.